ARTICLE SUMMARY:
Welcome to the August 20 edition of ‘Pathways’ Picks,’ MTS Market Pathways’ weekly roundup of the most important global medtech regulatory, reimbursement, and policy news. This week’s top pick is noteworthy action by Medicare in the mitral valve device space. Also: a spotlight on a newly proposed device pricing database in Brazil, a draft personalized implant guidance in China, and more.
Medicare is reconsidering its coverage policy for mitral valve repair devices in a way that could streamline future market growth. That news leads our Pathways’ Picks rundown of medtech policy items that should be on your radar this week.
